Dermatitis Herpetiformis: An Update on Diagnosis and Management

Area of Science:

• Immunodermatology
• Gastroenterology
• Autoimmune Diseases

Background:

• Dermatitis herpetiformis (DH) is a blistering skin rash and the primary cutaneous manifestation of celiac disease.
• While overt gastrointestinal symptoms are uncommon in DH, most patients exhibit small bowel villous atrophy or celiac-type inflammation.
• DH predominantly affects adults around 50 years old, with a slight male predominance.

Purpose of the Study:

• To summarize the key aspects of Dermatitis herpetiformis (DH), including its diagnosis, pathogenesis, and management.
• To highlight the strong association between DH and celiac disease and the diagnostic criteria for DH.
• To outline the recommended treatment strategies and long-term prognosis for individuals with DH.

Main Methods:

• Diagnosis of DH is confirmed by identifying granular immunoglobulin A deposits in the papillary dermis.
• The autoantigen transglutaminase 3 is found in immune complexes at the same dermal site.
• Prevalence data indicates a 1:8 ratio of DH to celiac disease, with decreasing DH incidence and increasing celiac disease incidence.

Main Results:

• A strict gluten-free diet (GFD) is the primary treatment for all DH patients, with uncontaminated oats permitted.
• Dapsone is often necessary initially to manage severe rash and itching but can typically be discontinued after approximately two years.
• Lifelong adherence to a GFD is crucial for maintaining remission and achieving an excellent long-term prognosis.

Conclusions:

• Dermatitis herpetiformis is a distinct autoimmune blistering disease strongly associated with celiac disease.
• Effective management relies on a combination of pharmacotherapy (dapsone) and strict adherence to a lifelong gluten-free diet.
• With appropriate dietary management, patients with DH can expect a normal quality of life and normal all-cause mortality.